MeVC27 (L), n=3 cell(s)

Main group: Visual Centrifugal Neurons; Neurotransmitter consensus prediction: unclear

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 - - - - - 127.0 244.7 15.3 1.0 - 388
1 - - - - - 96.0 369.7 27.3 2.0 - 495
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post - - - - - - - -
Pre - - - - - - - -
  AME
0 -
1 -
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 345.3
1 28.3

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses: 1164

Number of pre synapses: 1485

Number of output connections: 2977

Coverage factor: 1.7

Columnar completeness: 0.48

Area completeness: 0.60

Cell size (columns): 254

Lobula

Number of post synapses: 0

Number of pre synapses: 0

Number of output connections: 0

Coverage factor: 0

Columnar completeness: 0

Area completeness: 0

Cell size (columns): 0

Lobula Plate

Number of post synapses: 0

Number of pre synapses: 0

Number of output connections: 0

Coverage factor: 0

Columnar completeness: 0

Area completeness: 0

Cell size (columns): 0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#MeVC27 (L) % % cumu.
0 MeVP12 (R) ACh 250 83.3 21.9% 21.9%
1 Tm34 (R) Glu 151 50.3 13.2% 35.2%
2 aMe26 (R) ACh 146 48.7 12.8% 48.0%
3 MeVC3 (L) ACh 87 29.0 7.6% 55.6%
4 Cm9 (R) Glu 56 18.7 4.9% 60.5%
5 MeVP1 (R) ACh 38 12.7 3.3% 63.9%
6 Mi15 (R) ACh 35 11.7 3.1% 66.9%
7 MeVC8 (L) ACh 21 7.0 1.8% 68.8%
8 Dm2 (R) ACh 17 5.7 1.5% 70.3%
9 Cm4 (R) Glu 15 5.0 1.3% 71.6%
10 Cm3 (R) GABA 14 4.7 1.2% 72.8%
11 MeLo3b (R) ACh 14 4.7 1.2% 74.0%
12 MeTu4a (R) ACh 14 4.7 1.2% 75.3%
13 MeLo6 (R) ACh 13 4.3 1.1% 76.4%
14 MeVP14 (R) ACh 13 4.3 1.1% 77.5%
15 Cm20 (R) GABA 11 3.7 1.0% 78.5%
16 MeVC27 (L) unclear 11 3.7 1.0% 79.5%
17 MeVC21 (R) Glu 10 3.3 0.9% 80.4%
18 Mi10 (R) ACh 10 3.3 0.9% 81.2%
19 OA-AL2i4 (R) OA 10 3.3 0.9% 82.1%
20 Cm16 (R) Glu 8 2.7 0.7% 82.8%
21 Cm8 (R) GABA 8 2.7 0.7% 83.5%
22 MeLo5 (R) ACh 8 2.7 0.7% 84.2%
23 MeVP62 (R) ACh 8 2.7 0.7% 84.9%
24 aMe17a (R) Glu 7 2.3 0.6% 85.5%
25 MeVC20 (R) Glu 7 2.3 0.6% 86.1%
26 Cm5 (R) GABA 6 2.0 0.5% 86.7%
27 Dm-DRA1 (R) Glu 6 2.0 0.5% 87.2%
28 Cm21 (R) GABA 5 1.7 0.4% 87.6%
29 MeTu1 (R) ACh 5 1.7 0.4% 88.1%
30 Mi17 (R) GABA 5 1.7 0.4% 88.5%
31 Cm25 (R) Glu 4 1.3 0.4% 88.9%
32 Cm27 (R) Glu 4 1.3 0.4% 89.2%
33 Cm28 (R) unclear 4 1.3 0.4% 89.6%
34 MeTu3b (R) ACh 4 1.3 0.4% 89.9%
35 MeTu3c (R) ACh 4 1.3 0.4% 90.3%
36 MeVP15 (R) ACh 4 1.3 0.4% 90.6%
37 MeVP57 (R) unclear 4 1.3 0.4% 91.0%
38 MeVP6 (R) Glu 4 1.3 0.4% 91.3%
39 MeVPMe10 (L) Glu 4 1.3 0.4% 91.7%
40 Tm37 (R) Glu 4 1.3 0.4% 92.0%
41 5-HTPMPV03 (L) 5HT 3 1.0 0.3% 92.3%
42 Cm12 (R) GABA 3 1.0 0.3% 92.5%
43 Cm31b (R) GABA 3 1.0 0.3% 92.8%
44 Cm6 (R) GABA 3 1.0 0.3% 93.1%
45 MeTu4c (R) ACh 3 1.0 0.3% 93.3%
46 MeVC24 (R) Glu 3 1.0 0.3% 93.6%
47 MeVP32 (R) ACh 3 1.0 0.3% 93.9%
48 MeVP45 (R) ACh 3 1.0 0.3% 94.1%
49 MeVPMe12 (R) ACh 3 1.0 0.3% 94.4%

Outputs

  instance NT total connections connections /#MeVC27 (L) % % cumu.
0 Cm5 (R) GABA 246 82.0 8.3% 8.3%
1 Cm3 (R) GABA 228 76.0 7.6% 15.9%
2 Cm8 (R) GABA 162 54.0 5.4% 21.3%
3 MeVC21 (R) Glu 121 40.3 4.1% 25.4%
4 MeTu4c (R) ACh 115 38.3 3.9% 29.3%
5 Tm34 (R) Glu 104 34.7 3.5% 32.7%
6 Cm6 (R) GABA 91 30.3 3.1% 35.8%
7 MeTu4a (R) ACh 75 25.0 2.5% 38.3%
8 MeVP58 (R) unclear 72 24.0 2.4% 40.7%
9 OA-AL2i4 (R) OA 64 21.3 2.1% 42.9%
10 MeLo6 (R) ACh 63 21.0 2.1% 45.0%
11 MeVP6 (R) Glu 60 20.0 2.0% 47.0%
12 Cm28 (R) unclear 56 18.7 1.9% 48.9%
13 MeLo5 (R) ACh 56 18.7 1.9% 50.8%
14 Cm13 (R) Glu 52 17.3 1.7% 52.5%
15 Cm18 (R) Glu 50 16.7 1.7% 54.2%
16 Cm27 (R) Glu 48 16.0 1.6% 55.8%
17 MeVC20 (R) Glu 48 16.0 1.6% 57.4%
18 Cm4 (R) Glu 46 15.3 1.5% 58.9%
19 MeVP62 (R) ACh 43 14.3 1.4% 60.4%
20 Cm9 (R) Glu 39 13.0 1.3% 61.7%
21 Mi17 (R) GABA 39 13.0 1.3% 63.0%
22 MeLo3b (R) ACh 38 12.7 1.3% 64.3%
23 Cm7 (R) Glu 36 12.0 1.2% 65.5%
24 MeVP12 (R) ACh 36 12.0 1.2% 66.7%
25 TmY10 (R) ACh 36 12.0 1.2% 67.9%
26 MeTu4e (R) ACh 32 10.7 1.1% 69.0%
27 Tm37 (R) Glu 32 10.7 1.1% 70.0%
28 MeVP14 (R) ACh 30 10.0 1.0% 71.0%
29 MeVP61 (R) unclear 29 9.7 1.0% 72.0%
30 Dm2 (R) ACh 28 9.3 0.9% 73.0%
31 Tm5c (R) Glu 26 8.7 0.9% 73.8%
32 Cm16 (R) Glu 24 8.0 0.8% 74.6%
33 aMe17a (R) Glu 23 7.7 0.8% 75.4%
34 aMe9 (R) ACh 22 7.3 0.7% 76.1%
35 MeTu1 (R) ACh 20 6.7 0.7% 76.8%
36 Tm35 (R) Glu 20 6.7 0.7% 77.5%
37 MeVC3 (L) ACh 19 6.3 0.6% 78.1%
38 Mi16 (R) GABA 18 6.0 0.6% 78.7%
39 MeVP1 (R) ACh 16 5.3 0.5% 79.3%
40 Cm12 (R) GABA 15 5.0 0.5% 79.8%
41 Cm24 (R) Glu 15 5.0 0.5% 80.3%
42 Cm25 (R) Glu 15 5.0 0.5% 80.8%
43 MeTu3b (R) ACh 15 5.0 0.5% 81.3%
44 MeVP29 (R) ACh 15 5.0 0.5% 81.8%
45 TmY18 (R) ACh 15 5.0 0.5% 82.3%
46 Cm23 (R) Glu 14 4.7 0.5% 82.8%
47 MeVPMe12 (R) ACh 14 4.7 0.5% 83.2%
48 Pm4 (R) GABA 14 4.7 0.5% 83.7%
49 aMe26 (R) ACh 13 4.3 0.4% 84.1%
50 MeVP11 (R) ACh 13 4.3 0.4% 84.6%
51 Tm29 (R) Glu 13 4.3 0.4% 85.0%
52 Cm21 (R) GABA 12 4.0 0.4% 85.4%
53 Cm31b (R) GABA 12 4.0 0.4% 85.8%
54 Tm38 (R) ACh 12 4.0 0.4% 86.2%
55 MeVC27 (L) unclear 11 3.7 0.4% 86.6%
56 Mi10 (R) ACh 11 3.7 0.4% 87.0%
57 Cm19 (R) GABA 10 3.3 0.3% 87.3%
58 Tm16 (R) ACh 10 3.3 0.3% 87.6%
59 aMe17e (R) Glu 9 3.0 0.3% 87.9%
60 MeLo1 (R) ACh 9 3.0 0.3% 88.2%
61 MeVPLo1 (R) Glu 9 3.0 0.3% 88.5%
62 Mi19 (R) 5HT 9 3.0 0.3% 88.8%
63 Mi4 (R) GABA 9 3.0 0.3% 89.1%
64 Pm12 (R) Glu 9 3.0 0.3% 89.4%
65 Cm20 (R) GABA 8 2.7 0.3% 89.7%
66 MeVP15 (R) ACh 8 2.7 0.3% 90.0%
67 MeVP20 (R) unclear 8 2.7 0.3% 90.2%
68 MeVP32 (R) ACh 8 2.7 0.3% 90.5%
69 Mi15 (R) ACh 8 2.7 0.3% 90.8%
70 Pm13 (R) Glu 8 2.7 0.3% 91.0%
71 TmY17 (R) ACh 8 2.7 0.3% 91.3%
72 Lat3 (R) unclear 7 2.3 0.2% 91.5%
73 MeVC_unclear (R) Glu 7 2.3 0.2% 91.8%
74 Mi18 (R) GABA 7 2.3 0.2% 92.0%
75 Cm10 (R) GABA 6 2.0 0.2% 92.2%
76 MeTu3c (R) ACh 6 2.0 0.2% 92.4%
77 MeVC8 (L) ACh 6 2.0 0.2% 92.6%
78 Mi2 (R) Glu 6 2.0 0.2% 92.8%
79 Cm14 (R) GABA 5 1.7 0.2% 93.0%
80 MeVC24 (R) Glu 5 1.7 0.2% 93.2%
81 MeVP34 (R) unclear 5 1.7 0.2% 93.3%
82 MeVPMe5 (R) Glu 5 1.7 0.2% 93.5%
83 Tm20 (R) ACh 5 1.7 0.2% 93.7%
84 Tm4 (R) ACh 5 1.7 0.2% 93.8%
85 TmY9b (R) ACh 5 1.7 0.2% 94.0%
86 5-HTPMPV03 (L) 5HT 4 1.3 0.1% 94.1%
87 Cm11c (R) ACh 4 1.3 0.1% 94.3%
88 Cm22 (R) GABA 4 1.3 0.1% 94.4%
89 Cm30 (R) GABA 4 1.3 0.1% 94.5%
90 Dm-DRA1 (R) Glu 4 1.3 0.1% 94.7%
91 ME_unclear (R) ACh 4 1.3 0.1% 94.8%
92 MeVC2 (L) ACh 4 1.3 0.1% 94.9%
93 MeVP22 (R) GABA 4 1.3 0.1% 95.1%
94 MeVP46 (R) Glu 4 1.3 0.1% 95.2%
95 MeVPMe5 (L) Glu 4 1.3 0.1% 95.3%
96 MeVPMe8 (R) Glu 4 1.3 0.1% 95.5%
97 Tm32 (R) Glu 4 1.3 0.1% 95.6%
98 TmY9a (R) ACh 4 1.3 0.1% 95.7%
99 5-HTPMPV03 (R) 5HT 3 1.0 0.1% 95.8%
100 Cm34 (R) Glu 3 1.0 0.1% 95.9%
101 Dm20 (R) Glu 3 1.0 0.1% 96.0%
102 MeVC7a (L) ACh 3 1.0 0.1% 96.1%
103 T2a (R) ACh 3 1.0 0.1% 96.2%
104 Tm2 (R) ACh 3 1.0 0.1% 96.3%
105 Tm3 (R) ACh 3 1.0 0.1% 96.4%
106 Tm31 (R) Glu 3 1.0 0.1% 96.5%
107 Tm39 (R) ACh 3 1.0 0.1% 96.6%
108 Tm5Y (R) ACh 3 1.0 0.1% 96.7%
109 Tm9 (R) ACh 3 1.0 0.1% 96.8%